[HTML][HTML] Behavioural effects of using sulfasalazine to inhibit glutamate released by cancer cells: A novel target for cancer-induced depression

MG Nashed, RG Ungard, K Young, NJ Zacal… - Scientific reports, 2017 - nature.com
Despite the lack of robust evidence of effectiveness, current treatment options for cancer-
induced depression (CID) are limited to those developed for non-cancer related depression …

[PDF][PDF] Behavioural Effects of Using Sulfasalazine to Inhibit Glutamate Released by Cancer Cells: A Novel target for Cancer-Induced Depression

MG Nashed, RG Ungard, K Young, NJ Zacal… - depression (CID) - cyberleninka.org
Materials and Methods Cell culture. 4T1 murine mammary carcinoma cells (American Type
Culture Collection, Manassas, VA, USA) and TM40A murine non-tumourigenic mammary …

Behavioural Effects of Using Sulfasalazine to Inhibit Glutamate Released by Cancer Cells: A Novel target for Cancer-Induced Depression.

MG Nashed, RG Ungard, K Young, NJ Zacal… - Scientific …, 2017 - search.ebscohost.com
Despite the lack of robust evidence of effectiveness, current treatment options for cancer-
induced depression (CID) are limited to those developed for non-cancer related depression …

Behavioural Effects of Using Sulfasalazine to Inhibit Glutamate Released by Cancer Cells: A Novel target for Cancer-Induced Depression

MG Nashed, RG Ungard, K Young… - Scientific …, 2017 - pubmed.ncbi.nlm.nih.gov
Despite the lack of robust evidence of effectiveness, current treatment options for cancer-
induced depression (CID) are limited to those developed for non-cancer related depression …

Behavioural Effects of Using Sulfasalazine to Inhibit Glutamate Released by Cancer Cells: A Novel target for Cancer-Induced Depression

MG Nashed, RG Ungard, K Young, NJ Zacal… - Scientific Reports, 2017 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Despite the lack of robust evidence of
effectiveness, current treatment options for cancer-induced depression (CID) are limited to …

[HTML][HTML] Behavioural Effects of Using Sulfasalazine to Inhibit Glutamate Released by Cancer Cells: A Novel target for Cancer-Induced Depression

MG Nashed, RG Ungard, K Young, NJ Zacal… - Scientific …, 2017 - ncbi.nlm.nih.gov
Despite the lack of robust evidence of effectiveness, current treatment options for cancer-
induced depression (CID) are limited to those developed for non-cancer related depression …

Behavioural Effects of Using Sulfasalazine to Inhibit Glutamate Released by Cancer Cells: A Novel target for Cancer-Induced Depression

MG Nashed, RG Ungard, K Young, NJ Zacal… - Scientific …, 2017 - ui.adsabs.harvard.edu
Despite the lack of robust evidence of effectiveness, current treatment options for cancer-
induced depression (CID) are limited to those developed for non-cancer related depression …

Behavioural Effects of Using Sulfasalazine to Inhibit Glutamate Released by Cancer Cells: A Novel target for Cancer-Induced Depression.

MG Nashed, RG Ungard, K Young, NJ Zacal… - Scientific …, 2017 - europepmc.org
Despite the lack of robust evidence of effectiveness, current treatment options for cancer-
induced depression (CID) are limited to those developed for non-cancer related depression …

[PDF][PDF] Behavioural Effects of Using Sulfasalazine to Inhibit Glutamate Released by Cancer Cells: A Novel target for Cancer-Induced Depression

MG Nashed, RG Ungard, K Young, NJ Zacal… - depression (CID) - researchgate.net
Materials and Methods Cell culture. 4T1 murine mammary carcinoma cells (American Type
Culture Collection, Manassas, VA, USA) and TM40A murine non-tumourigenic mammary …

Behavioural Effects of Using Sulfasalazine to Inhibit Glutamate Released by Cancer Cells: A Novel target for Cancer-Induced Depression.

MG Nashed, RG Ungard, K Young, NJ Zacal… - Scientific …, 2017 - europepmc.org
Despite the lack of robust evidence of effectiveness, current treatment options for cancer-
induced depression (CID) are limited to those developed for non-cancer related depression …